Pratia
Anna Dryja is currently the Medical Director/ Principal Investigator at MTZ powered by Pratia, managing clinical research sites and leading various medical studies. With a background as a Specialist in Clinical Oncology, Anna has experience in treating various cancers and administering different therapies. Prior to their current role, Anna held positions in medical management and clinical operations at various pharmaceutical companies. Anna holds a MD in Medicine and a Master of Business Administration degree.
Pratia
Pratia is a Research Site Network with 90+ Centers across 6 countries in Europe. With 700+ Clinical Trials carried out since 2012, Pratia brings Tech-savvy, adaptable solutions in innovative treatments at your convenience. It is a Platform for innovative medicine, which offers the best mix of Sites, expertise, access to Patients to each protocol, as well as close collaboration with the local healthcare systems. Pratia can address the dynamically changing requirements in the industry, including Remote Monitoring and Decentralized Studies. In 2014 Pratia joined Neuca Plc. - the leading organization in the Pharmaceutical Wholesaling and the Healthcare Industry.